Form4insider filings, from the source

SEC Form 4 · accession 0001093557-18-000254

DEXCOM INC · DXCM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Andrew K Balo
Officer — EVP, Reg. Strategy, Clinical
Period of report
Dec 14, 2018
Accepted (ET)
Dec 18, 2018 · 6:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Dec 14, 2018S627$120.2302D77,478D
Common StockF1,F4,F3Dec 14, 2018S4,373$121.3772D73,105D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses